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Abstract
After years of query, we found that hoof of mule, a compound with contraceptive effect, had been used
more than a century ago by the nomadic populations of Iran. We tested the effects of hoof on female
rats. Hoof was administered orally (0.12 g/kg) for 3 days and the rats were mated on day 10 after the last
administration. The mean number of pups 5 hours after delivery on day 21 was 14.67 ± 0.21 for the
control group (Group-A), 4.16 ± 0.40 for rats experiencing their first pregnancy (Group-B), and no pups
for rats experiencing their second pregnancy (Group C). Analysis of the uterus demonstrated failure of
embryo implantation in one of the fallopian tubes of Group B, and no implantation in Group C.
Assessment of serum levels of estradiol and progesterone showed completely opposite trends to the
normal situation of hormonal changes after delivery. In summary, hoof of mule would appear to act
through a complicated mechanism that may involve hormonal pathways. This new claim requires
further extensive studies to determine the exact mechanism. The effective compound in hoof that affects
hormonal balance and causes contraception is currently being analysed and identified.
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Introduction
The Oral Contraceptive (OC) pill is the most common form of
hormonal contraception used in the United States [1-3].
However, more than 1 million unwanted pregnancies in the
United States are believed to result from OC failure, misuse, or
discontinuation [4]. For this reason, many women around the
world opt for surgical methods for permanent contraception
[5,6]. A study by Patil et al. [7] concluded that more research
and development is needed into new nonsurgical methods so
that women can be guaranteed access to contraceptive methods
that best meet their desires and needs, while reducing financial
and logistical burdens. One possibly safer and effective
alternative could be the use of natural contraceptive drugs. Our
years of query among the nomadic people in the provinces of
Fars and Kohgiluyeh and Boyer-Ahmad, Iran, revealed the use
of a natural compound from hoof as a contraceptive. A number
of elderly women claimed that their mothers and grandmothers
had used hoof to prevent pregnancy about a century ago, with
the desired result. This pilot experimental therefore




We used adult male (4 months old), virgin female (3 months
old), and non-virgin female (4 months old) Wistar rats. All
experimental protocols were approved by the Institutional
Animal Care and Use Committee and Ethics Committee of
Yasuj University of Medical Science, in accordance with the
provisions of the Declaration of Helsinki (as revised in Brazil
in 2013). All efforts were made to minimize the number of
animals and decrease their suffering.
Grouping and treatment
Small pieces of hoof were removed and ground into a powder.
We chose this way of administration as that is how the nomadic
woman used this compound as a contraceptive drug. Twenty-
four adult female rats were divided into four groups, as
follows: (A) Control 15, PBS-treated rat; (B) Control 21, PBS-
treated rat; (C) First pregnancy experience, hoof -treated rat;
(D) Second pregnancy experience, hoof-treated rat. Rats in the
control 15 group were sacrificed on day 15 of pregnancy. All
treatments (0.12 g/kg) were administered orally for 3 days,
followed by 10 days without any other interventions.
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Mating
Ten days after the last administration of hoof, 24 female rats
and 12 male rats were used for mating at a male: female ratio
of 1:2. Each cage of female rats, containing 2 females, was
housed overnight with one sexually mature male rat, and
vaginal smears were used to evaluate the right time for mating
and pregnancy. At the beginning of the light phase the
following morning, vaginal smears were obtained from all
females and observed with a light microscope to check for the
presence of sperm. Gestation Day (GD) 0 was deemed the day
that sperm were present. After successful mating, all female
rats were housed singly in plastic bottom cages with additional
nesting materials. All animals were maintained and fed under
standard laboratory conditions under artificial 12-h light/dark
cycle (lights on from 08:00 h) and temperature was maintained
at 20-24˚C with relative humidity at 35-60%.
Gestation period and deliveries
The expected day of delivery (birth) in rats is GD 21-22.
Pregnant females were checked hourly by at least two
investigators from day 19 to monitor for possible delivery and
pup mortalities. The rats started to deliver at day 21. Rats were
anesthetized and sacrificed with 4% chloral hydrate, 5 hours
after the first sign of delivery (all deliveries were done during
this time). Note: some rats did not show any delivery. We
sacrificed all rats at the same time to ensure the same point
post mating. The pups were counted and serum, ovary, and
uterus samples were prepared from the adult rats. The
implantation sites were counted in the uterus of all rats.
Measurement of serum hormone levels
Estradiol and progesterone levels in the serum were determined
by using ELISA kits according to the kit protocol (Sigma
Aldrich, USA).
Statistical analysis
Results are presented as averages, with error bars indicating the
standard error of the mean (Mean ± SEM). Graph Pad Prism
(Version 6.01, San Diego, CA, USA) software was used to
perform statistical analyses. Ordinary one-way ANOVA,
followed by Sidak’s multiple comparison test with a single
pooled variance, was used to analyse the data. Significance is
indicated as p<0.05, p<0.01, p<0.001, ****p<0.0001.
Results
The effect of hoof administration on the mean number of pups
is shown in Figure 1 and Table 1. The rats in the control group
had 14.67 ± 0.21 pups with no mortalities. This value
decreased to 5.00 ± 0.51 pups in Hoof-treated rats that were
experiencing a first pregnancy (p<0.0001), with a mortality of
0.84 ± 0.40 pups in this group. Hoof administration completely
prevented pregnancy in the rats experiencing a second
pregnancy, and there were no pups on day 21.
Representative images of isolated uteruses and ovaries showed
morphologically marked differences between the groups. In the
control group, the uteruses were in the normal condition after
delivery, as implantation sites were clearly apparent as shown
in Figure 2A. By contrast, the rats in first pregnancy group
showed abnormal conditions, such as dystrophy in one of the
Fallopian tubes in 4 out of 6 animals, with no implantation
sites. The overall number of implantation sites in the other
Fallopian tubes was lower than in the control as shown in
Figure 2B. The rats in the second pregnancy group did not
show any implantation sites in uterus as shown in Figure 2C.
Figure 1. The mean number of pups in three different experimental
groups. Data are expressed as Mean ± SEM from six rats per group.
(****p<0.0001).
Figure 2. Representative images of the uterus in different groups of
rats. Images were taken 5 hours after delivery (on day 21 post
mating). The red line indicates the two horns of uterus.
Figure 3 shows the serum levels of estradiol (10.70 ± 1.75
ng/ml) and progesterone (47.5 ± 1.50 pg/ml) in normal
pregnant rats on day 15 (control 15). These values increased to
85.00 ± 2.00 ng/ml (p<0.01) for estradiol and decreased to 4.43
± 0.80 pg/ml (p<0.05) for progesterone in the control group at
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day 21 (5 hours post-delivery). Administration of Hoof
significantly decreased the serum estradiol to 52.10 ± 2.90
pg/ml in first pregnancy group (p<0.01, compared to the
control group on day 21) and to 43.5 ± 2.50 pg/ml in the
second pregnancy group (p<0.01, compared to the control
group on day 21). By contrast, progesterone levels were
dramatically enhanced in both the first and second pregnancy
groups, reaching levels of 9.1 ± 0.49 and 15.87 ± 1.27 ng/ml
(p<0.001), respectively.
Figure 3. Serum estradiol and progesterone in different groups.
Control at day 15 shows serum level of estradiol and progesterone on
day 15 of pregnancy. (A). serum level of estradiol was measured on
day 15 and also 21, 5 hours after delivery. (B). same as the estradiol,
progesterone level was measured. Both group of the first and second
pregnancy experiencing rats received hoof orally for 3 continuous
days. Data are expressed as Mean ± SEM. (*) p<0.05, (**) p<0.01
and (***) p<0.001.
Table 1. The effect of hoof on the number of pups.






14.67 ± 0.21 4.16 ± 0.40 0
Number of dead
pups
0 0.83 ± 0.40 0
Total 14.67 ± 0.21 5.00 ± 0.51 0
Discussion
This study presents a novel view of the use of natural
compounds to improve human lives by confirming the
contraceptive effect of hoof of mule claimed by nomadic
women. The pup counts recorded in this study verified that
hoof clearly acts like contraceptive drug. However, the hoof
effects differed between cases that experienced pregnancy for
the first versus the second time, suggesting that the underlying
mechanism of action of this compound is unlike that of
commonly used contraceptive drugs. The freshly isolated
uteruses showed no signs of implantation sites in the rats
experiencing a second pregnancy, but this effect was not as
complete during the first pregnancy, where some implantation
sites were found.
Measurements of estradiol and progesterone concentrations
revealed completely opposite results in the hoof-treated rats
compared to the normal conditions reported in other studies.
For example, Puri and colleagues showed a clear pattern of
progesterone and estradiol changes during pregnancy in rats
[8], where the levels of progesterone in both uterine vein
plasma and uterine tissue started to decline on day 19 of
pregnancy, but showed no further significant declines to day
22. Conversely, the levels of estradiol began to rise after day
20 of pregnancy, reaching a peak level on day 21. During
delivery, the estradiol level was about 3 to 4 fold higher than
on day 15 to 19 of pregnancy. Our measurements of hormone
levels on day 15 and day 21, the same time range used by Puri
et al., indicated that hoof administration induced a pathological
state. Most probably, a change in the secretion patterns of sex
hormones, including progesterone and estradiol, is one of the
possible mechanisms underlying the effects of hoof on
pregnancy. In contrast to our results, a study on normal humans
showed a downward trend for progesterone concentration after
delivery for several days [9].
Our queries of the nomadic women who have used hoof
revealed that they did not experience any side effects,
including cerebral vascular, gastrointestinal, and cardiac
effects. Numerous studies have used oestrogen plus progestin
to validate the beneficial role of these hormones in different
patients and healthy cases [10-12], Chemically, hoof consists
of protein, and variations in the amino acid content of proteins
have been shown in hoof from different sources [13,14]. These
amino acids and their ratios could therefore be possible
effective ingredients that need further analysis.
In summary, we have confirmed the potential of hoof for the
prevention of pregnancy in these initial experiments, but
further studies are needed. The active compounds are under
analysis, but overall, hoof of mule appears to be a promising
natural drug for contraception.
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